Previous evidence on postdiagnosis body fatness and mortality after breast cancer was
graded as limited‐suggestive. To evaluate the evidence on body mass index (BMI), waist …

Epidemiology studies have demonstrated a clear association between obesity and the
development of several distinct malignancies, with excessive visceral adiposity being an …

The impact of body mass index (BMI) on treatment outcomes in patients with cancer is
gaining increasing attention given the limited data available. The aim of this study was to …

Simple Summary The recent addition of cyclin-dependent kinase 4 (CDK4) and CDK6
inhibitors (palbociclib, ribociclib, abemaciclib) to endocrine therapy have remarkably …

PURPOSE BMI affects breast cancer risk and prognosis. In contrast to cytotoxic
chemotherapy, CDK4/6 inhibitors are given at a fixed dose, irrespective of BMI or weight …

Simple Summary Obesity is a poor prognostic factor for patients with breast cancer, resulting
in increased risk of recurrence and death due to breast cancer. Obesity can affect both the …

Background The proportion of patients with breast cancer and obesity is increasing. While
the therapeutic landscape of breast cancer has been expanding, we lack knowledge about …

Simple Summary Although people with metastatic cancer are living longer with their
disease, they are faced with challenges that can interfere with their quality of life. These …

While many studies have evaluated the relationship between BMI and breast cancer
outcomes, it is unclear whether this relationship is consistent between early breast cancer …

Abstract Background High Body mass index (BMI) is a risk factor for breast cancer among
postmenopausal women and an adverse prognostic factor in early-stage. Little is known …